Sagimet Biosciences Inc
NASDAQ:SGMT

Watchlist Manager
Sagimet Biosciences Inc Logo
Sagimet Biosciences Inc
NASDAQ:SGMT
Watchlist
Price: 5.18 USD -13.95% Market Closed
Market Cap: 157.4m USD
Have any thoughts about
Sagimet Biosciences Inc?
Write Note

Sagimet Biosciences Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sagimet Biosciences Inc
Total Equity Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Sagimet Biosciences Inc
NASDAQ:SGMT
Total Equity
$91.1m
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Equity
$6B
CAGR 3-Years
-24%
CAGR 5-Years
N/A
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Total Equity
$18.4B
CAGR 3-Years
-5%
CAGR 5-Years
-2%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Total Equity
$7.5B
CAGR 3-Years
-3%
CAGR 5-Years
-7%
CAGR 10-Years
-11%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Equity
$15.6B
CAGR 3-Years
18%
CAGR 5-Years
24%
CAGR 10-Years
30%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Equity
$29.3B
CAGR 3-Years
19%
CAGR 5-Years
23%
CAGR 10-Years
28%

See Also

What is Sagimet Biosciences Inc's Total Equity?
Total Equity
91.1m USD

Based on the financial report for Dec 31, 2023, Sagimet Biosciences Inc's Total Equity amounts to 91.1m USD.

What is Sagimet Biosciences Inc's Total Equity growth rate?
Total Equity CAGR 3Y
11%

Over the last year, the Total Equity growth was 229%. The average annual Total Equity growth rates for Sagimet Biosciences Inc have been 11% over the past three years .

Back to Top